ARCHIVES

Stephen Gruber Named Director at USC Norris; TGen and Cedars-Sinai to Coordinate Phase I Trials.

This article is from The Cancer Letter archive.

Vol. 37 No. 39 | October 21, 2011

Download PDF Visit The Full Archive

Related Articles

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

CCOP Review Committees Listed

February 6, 1987

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002